| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/09/2002 | US6369027 Osteoprotegerin |
| 04/09/2002 | US6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |
| 04/09/2002 | US6368854 Hypoxia mediated neurogenesis |
| 04/09/2002 | US6368852 A peptide capable of inducing cytotoxic t lymphocytes, immune response; anticarcinogenic agents |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368832 A polypeptide of a major capsid protein; diagnosis and therapy for skin cancer; vaccines |
| 04/09/2002 | US6368785 Anti-coagulation of blood, plasma or synovial fluid products using iso-citrate |
| 04/09/2002 | US6368636 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 04/09/2002 | US6368614 Biological material, method of preparing such materials |
| 04/09/2002 | US6368580 Gastrointestinal disorders; oral administering bacillus |
| 04/09/2002 | US6367479 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto |
| 04/09/2002 | CA2263800C A thrombin blood fraction for use in a medical procedure |
| 04/09/2002 | CA2093219C Amides of antibiotic ge 2270 factors |
| 04/09/2002 | CA2033823C Combination of gla or dgla and selenium in psychiatric disorder treatment |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002026977A1 Host cell obtained by transferring vhl gene into cancer cell or embryonic stem cell and expressing |
| 04/04/2002 | WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 04/04/2002 | WO2002026941A2 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | WO2002026939A2 Microfabrication of membranes for the growth of cells |
| 04/04/2002 | WO2002026258A2 Treatment of immune-mediated diseases by oral administration of plasma fractions |
| 04/04/2002 | WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids |
| 04/04/2002 | WO2002008435A8 Codon-optimized papilloma virus sequences |
| 04/04/2002 | WO2001093893A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 04/04/2002 | WO2001092320A3 Use a high-molecular-weight extracellular haemoglobin as blood substitute |
| 04/04/2002 | WO2001090306A3 Compositions and methods for modulating tumor specific expression |
| 04/04/2002 | WO2001088106A3 Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085184A3 Nontoxic vernix compositions and method of producing |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001071017A3 Modified nodavirus rna for gene delivery |
| 04/04/2002 | WO2001068837A3 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 04/04/2002 | WO2001064227A3 Androgenic activity of eucommia ulmoides extracts |
| 04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
| 04/04/2002 | WO2001058494A3 Gene therapy for treating ocular-related disorders |
| 04/04/2002 | WO2001051616A3 Techniques for growth and differentiation of human pluripotent stem cells |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
| 04/04/2002 | WO2000070099A3 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 04/04/2002 | US20020040128 Carbohydrate-blood protein complex for us as an oxygen transporter |
| 04/04/2002 | US20020040127 Nucleotide sequences which code tumor protein for use in diagnosis, prevention and treament of tumors |
| 04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
| 04/04/2002 | US20020039790 Adjustment of immunology of cells |
| 04/04/2002 | US20020039789 Method for production of neuroblasts |
| 04/04/2002 | US20020039788 Xenogenic exograft for use in the treatment of vision defects |
| 04/04/2002 | US20020039787 Method for culturing cells |
| 04/04/2002 | US20020039786 Generating progenitor cells; provide cells for organ grafting, propagate cells, recover cells |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/04/2002 | US20020039724 Neural progenitor cell populations |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039590 Nontoxic vernix compositions and method of producing |
| 04/04/2002 | US20020039587 Compositions and methods for treating hand and wrist discomfort |
| 04/04/2002 | US20020039576 Controller lymphocytes |
| 04/04/2002 | US20020039569 Activation; separation |
| 04/04/2002 | DE10047272A1 Verfahren zur Fusion von dendritischen Zellen mit erkrankten Gewebezellen, insbesondere Tumorzellen und Medien für solche Verfahren Process for the fusion of dendritic cells with diseased tissue cells, particularly tumor cells and media for such methods |
| 04/04/2002 | DE10046643A1 Aqueous emulsion for internal administration used for treating inflammatory conditions e.g. of oral cavity, nasal passages and respiratory tract contains marmot oil |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | DE10043937A1 Production of trivalent chromium complex compound useful for preparing milk product for controlling blood sugar involves addition of lactoferrin or whey protein to a trivalent chromium compound |
| 04/04/2002 | CA2424062A1 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | CA2423805A1 Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
| 04/03/2002 | EP1193272A1 Single-chain insulin analogs |
| 04/03/2002 | EP1192948A2 Use of HSV mutant in the treatment of cancer |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 04/03/2002 | EP1192265A1 Anti-viral vectors |
| 04/03/2002 | EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 04/03/2002 | EP1192245A2 Methods for the propagation of lytic organisms |
| 04/03/2002 | EP1192243A1 Method for enhancing hematopoiesis |
| 04/03/2002 | EP1192180A1 Product from starfish |
| 04/03/2002 | EP1192179A2 Compound derived from an offset orf of the ice gene |
| 04/03/2002 | EP1192176A1 49 human secreted proteins |
| 04/03/2002 | EP1191938A2 Immunity generation |
| 04/03/2002 | EP0859957B1 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers |
| 04/03/2002 | EP0726941B1 Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 04/03/2002 | EP0621786B1 Induced tolerance to xenografts |
| 04/03/2002 | CN1343185A Vital matter and producing method thereof |
| 04/03/2002 | CN1343125A Immunostimulant bacterial membrane tractions in cancer treatment |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/03/2002 | CN1343123A Pharmaceutical and animal fodder comprising fermented fish |
| 04/03/2002 | CN1342491A Medicine 'Suyusan' for treating intractable ulcer |
| 04/03/2002 | CN1342490A Process for preparing staltic-antagic medicine to treat trauma |
| 04/03/2002 | CN1342489A Liquid omphalotherapeutic medicine for treating abdominalgia |
| 04/03/2002 | CN1342488A Chinese medicine preparation 'Jiangudan' |
| 04/03/2002 | CN1342486A Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing |
| 04/03/2002 | CN1342485A Exterior-applied medical wine for treating trauma |
| 04/03/2002 | CN1342484A Pile ointment |
| 04/03/2002 | CN1342482A Chinese patent medicine for treating nenoxenia |
| 04/03/2002 | CN1342477A Quick-acting hypertension capsule |
| 04/03/2002 | CN1342470A Medicine for eliminating bursa |
| 04/03/2002 | CN1342468A Capsule for treating rheumatic and rheumatoid arthritis and its preparing process |
| 04/03/2002 | CN1342464A Antivirus antioxidizing active extract of proplis and its molecular inclusion compound |
| 04/03/2002 | CN1342463A Health-care propolis-chitosan medicine |
| 04/03/2002 | CN1342462A Composite medicine for treating rheumatoid arthritis |
| 04/03/2002 | CN1342461A Process for preparing embryo nutrient |
| 04/03/2002 | CN1342460A Chinese medicine method for preparing biological product by inducing effect mass in animal body |
| 04/03/2002 | CN1081924C Pharmaceutical composition comprising plant worms and muirapuama |
| 04/03/2002 | CN1081920C Herba pteridis semipinnatae extract and its medicinal composite |
| 04/02/2002 | US6365569 To protect animals from diseases caused by parasitic helminths |
| 04/02/2002 | US6365405 Compositions of chondrocytes, preparation and utilization |
| 04/02/2002 | US6365404 Reducing viral replication of human immunodeficiency virus by administering t-lymphocytes which have been rendered incapable of viral replication and have increased cell surface membrane density of viral receptors |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |